Compounds > carbogen
Page last updated: 2024-08-24

carbogen and Lymph Node Metastasis

carbogen has been researched along with Lymph Node Metastasis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baddeley, H; Caine, LA; Griffiths, JR; Hoskin, PJ; Howe, FA; Powell, ME; Robinson, SP; Saunders, MI; Taylor, NJ; Thoumine, M1
Kaanders, JH; Liefers, J; Marres, HA; Pop, LA; van Daal, WA; van den Hoogen, FJ; van der Kogel, AJ1

Other Studies

2 other study(ies) available for carbogen and Lymph Node Metastasis

ArticleYear
The response of human tumors to carbogen breathing, monitored by Gradient-Recalled Echo Magnetic Resonance Imaging.
    International journal of radiation oncology, biology, physics, 1997, Oct-01, Volume: 39, Issue:3

    Topics: Administration, Inhalation; Carbon Dioxide; Carcinoma, Squamous Cell; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasms; Oxygen

1997
Accelerated radiotherapy with carbogen and nicotinamide (ARCON) for laryngeal cancer.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 1998, Volume: 48, Issue:2

    Topics: Actuarial Analysis; Administration, Inhalation; Administration, Oral; Adult; Aged; Aged, 80 and over; Carbon Dioxide; Carcinoma; Cell Division; Cell Hypoxia; Dose Fractionation, Radiation; Feasibility Studies; Female; Follow-Up Studies; Humans; Laryngeal Neoplasms; Laryngectomy; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Niacinamide; Oxygen; Prospective Studies; Radiation-Sensitizing Agents; Radiotherapy Dosage; Salvage Therapy; Survival Rate

1998